← Back to catalogue

2, 0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (100 cm)

EUDAMED

Class IIa (EU MDR)

Ref VFL1420020-100Model Percutaneous Transluminal Angıoplasty (Pta) Dilatation CathetersRef VFL1420020-140Model Percutaneous Transluminal Angıoplasty (PTA) Dilatation Catheters

by Alfatip Ki̇mya Kozmeti̇k Tibbi̇ Malz. San. Ve Ti̇c. Ltd. Şti̇.

Identity

Trade Name
2,0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (100 cm) EUDAMED
2,0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (140 cm) EUDAMED
Device Name
2,0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (100 cm) EUDAMED
2,0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (140 cm) EUDAMED
Model / Reference
Percutaneous Transluminal Angıoplasty (Pta) Dilatation Catheters EUDAMED
VFL1420020-100 EUDAMED
VFL1420020-140 EUDAMED

Identifiers

Primary DI / UDI-DI
08683851831980 EUDAMED
08683851832444 EUDAMED
Basic UDI-DI
B-08683851831980 EUDAMED
B-08683851832444 EUDAMED
EMDN Code
C010402020101 PTA BALLOON DILATATION CATHETERS EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Türkiye EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

2, 0 X 20 mm VeniFlow 0.014” PTA Balloon Dilatation Catheter (100 cm) by Alfatip Ki̇mya Kozmeti̇k Tibbi̇ Malz. San. Ve Ti̇c. Ltd. Şti̇. — Class IIa — MDD…

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
TR-MF-000040075

Sources (2)

  • EUDAMED 61e56f25-6473-46c0-86f9-6bff1800af80 61 fields · synced Oct 8, 2026
  • EUDAMED 2fbf337c-b819-49bc-929e-64e20a00289e 61 fields · synced Jul 31, 2026